102 related articles for article (PubMed ID: 9011166)
1. [Ebastine : treatment of perennial rhinitis in the child].
Benavente V; Eseverri JL; Botey J; Marin A
Allerg Immunol (Paris); 1996 Oct; 28(8):277-81. PubMed ID: 9011166
[TBL] [Abstract][Full Text] [Related]
2. Comparison of efficacy and safety of cetirizine and ebastine in patients with perennial allergic rhinitis.
Murris-Espin M; Melac M; Charpentier JC; Didier A
Ann Allergy Asthma Immunol; 1998 May; 80(5):399-403. PubMed ID: 9609610
[TBL] [Abstract][Full Text] [Related]
3. [Ebastine vs terfenadine in allergic rhinitis].
Terán Ortíz L; Flores Sandoval G; Orea Solano M; Camarena A
Rev Alerg; 1993; 40(4):82-5. PubMed ID: 7908244
[TBL] [Abstract][Full Text] [Related]
4. Ebastine in perennial allergic rhinitis.
Picado Vallés C; Cadahia García A; Cisteró Bahima A; Cano Cantudo L; Sanz Amaro A; Zayas Sanza JM
Ann Allergy; 1991 Dec; 67(6):615-8. PubMed ID: 1684273
[TBL] [Abstract][Full Text] [Related]
5. Ebastine increases IFN-gamma production in patients with persistent allergic rhinitis.
Ciprandi G; Cirillo I; Pistorio A; Di Gioacchino M; Fenoglio D
J Biol Regul Homeost Agents; 2009; 23(1):31-6. PubMed ID: 19321044
[TBL] [Abstract][Full Text] [Related]
6. Ebastine in allergic rhinitis and chronic idiopathic urticaria.
Sastre J
Allergy; 2008 Dec; 63 Suppl 89():1-20. PubMed ID: 19032340
[TBL] [Abstract][Full Text] [Related]
7. [Ebastine (kestine 20) in therapy of allergic rhinitis].
Petrovskaia TIu; Sergeeva TA; Lopatin AS
Vestn Otorinolaringol; 2007; (3):51-3. PubMed ID: 17768822
[No Abstract] [Full Text] [Related]
8. Evaluation of the drug monitoring programme of azelastine hydrochloride nasal spray in the treatment of allergic rhinitis in children under 13 years of age.
Wober W; Diez Crespo CD; Bähre M
Arzneimittelforschung; 1997 Jul; 47(7):841-4. PubMed ID: 9272242
[TBL] [Abstract][Full Text] [Related]
9. Rupatadine 10 mg and ebastine 10 mg in seasonal allergic rhinitis: a comparison study.
Guadaño EM; Serra-Batlles J; Meseguer J; Castillo JA; De Molina M; Valero A; Picado C;
Allergy; 2004 Jul; 59(7):766-71. PubMed ID: 15180765
[TBL] [Abstract][Full Text] [Related]
10. [Multicenter study of satisfaction with fast-dissolving ebastine, 20 mg/ day, in Mexican patients with allergic rhinitis].
Aguilar D; Arias A; Báez C; González S; Hernández D; Linares FJ; López A; Macías A; Martínez A; Martínez HM; Martínez N; Mogica MD; Paz D; Rojo I; Sánchez A
Rev Alerg Mex; 2009; 56(2):36-40. PubMed ID: 19526952
[TBL] [Abstract][Full Text] [Related]
11. [Investigation of the efficacy and tolerability of azelastine nasal spray versus ebastine tablets in patients with seasonal allergic rhinitis].
Antépara I; Jaúregui I; Basomba A; Cadahia A; Feo F; García JJ; Gonzalo MA; Luna I; Rubio M; Vázquez M
Allergol Immunopathol (Madr); 1998; 26(1):9-16. PubMed ID: 9585822
[TBL] [Abstract][Full Text] [Related]
12. Suppression of the skin reaction to histamine by ebastine.
Nelson HS; Bucher B; Buchmeier A; Oppenheimer J; Garcia J
Ann Allergy Asthma Immunol; 1995 May; 74(5):442-7. PubMed ID: 7749977
[TBL] [Abstract][Full Text] [Related]
13. [Ebastine in the treatment of seasonal allergic rhinitis].
Il'ina NI; Balabolkin II; Blokhin BM; Goriachkina LA; Kolganova NA; Pampura AN; Sidorenko IV
Ter Arkh; 1998; 70(9):79-81. PubMed ID: 9821236
[TBL] [Abstract][Full Text] [Related]
14. [Efficacy of levocabastine in perennial rhinitis].
Pacor ML; Biasi D; Maleknia T; Carletto A; Lunardi C
Clin Ter; 1996 Jun; 147(6):295-8. PubMed ID: 8925638
[TBL] [Abstract][Full Text] [Related]
15. Ebastine improves nasal symptoms and airflow and affects response to decongestion test in patients with persistent allergic rhinitis: a pilot study.
Ciprandi G; Cirillo I; Mora F; La Rosa M
Allergy Asthma Proc; 2007; 28(5):578-81. PubMed ID: 17883885
[TBL] [Abstract][Full Text] [Related]
16. The effects of short-term immunotherapy using molecular standardized grass and rye allergens compared with symptomatic drug treatment on rhinoconjunctivitis symptoms, skin sensitivity, and specific nasal reactivity.
Klimek L; Mewes T; Wolf H; Hansen I; Schnitker J; Mann WJ
Otolaryngol Head Neck Surg; 2005 Oct; 133(4):538-43. PubMed ID: 16213926
[TBL] [Abstract][Full Text] [Related]
17. Comparative clinical studies with ebastine: efficacy and tolerability.
Luria X
Drug Saf; 1999; 21 Suppl 1():63-7; discussion 81-7. PubMed ID: 10597869
[TBL] [Abstract][Full Text] [Related]
18. A placebo-controlled evaluation of butterbur and fexofenadine on objective and subjective outcomes in perennial allergic rhinitis.
Lee DK; Gray RD; Robb FM; Fujihara S; Lipworth BJ
Clin Exp Allergy; 2004 Apr; 34(4):646-9. PubMed ID: 15080820
[TBL] [Abstract][Full Text] [Related]
19. Open-label evaluation of azelastine nasal spray in patients with seasonal allergic rhinitis and nonallergic vasomotor rhinitis.
Lieberman P; Kaliner MA; Wheeler WJ
Curr Med Res Opin; 2005 Apr; 21(4):611-8. PubMed ID: 15899111
[TBL] [Abstract][Full Text] [Related]
20. A 12-week, placebo-controlled study of the efficacy and safety of ebastine, 10 and 20 mg once daily, in the treatment of perennial allergic rhinitis. Multicentre Study Group.
Bousquet J; Gaudaño EM; Palma Carlos AG; Staudinger H
Allergy; 1999 Jun; 54(6):562-8. PubMed ID: 10435469
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
